rs797044910
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000371953.8(PTEN):c.71A>G(p.Asp24Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D24E) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000371953.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.71A>G | p.Asp24Gly | missense_variant | 1/9 | ENST00000371953.8 | NP_000305.3 | |
PTEN | NM_001304717.5 | c.590A>G | p.Asp197Gly | missense_variant | 2/10 | NP_001291646.4 | ||
PTEN | NM_001304718.2 | c.-635A>G | 5_prime_UTR_variant | 1/9 | NP_001291647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTEN | ENST00000371953.8 | c.71A>G | p.Asp24Gly | missense_variant | 1/9 | 1 | NM_000314.8 | ENSP00000361021 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
PTEN hamartoma tumor syndrome Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals | Nov 23, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2020 | In summary, this is a rare missense variant that is absent in the general population and has been reported in several affected individuals. For these reasons, it has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has been reported in several individuals affected with Cowden or Cowden-like syndrome (PMID: 21194675, 22503188, 24498881). ClinVar contains an entry for this variant (Variation ID: 208723). This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with glycine at codon 24 of the PTEN protein (p.Asp24Gly). The aspartic acid residue is moderately conserved and there is a moderate physicochemical difference between aspartic acid and glycine. - |
Cowden syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Sep 25, 2023 | This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 21194675, 22503188, 24901346, 10232405, 23335809]. Functional studies indicate this variant impacts protein function [PMID: 17213812]. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2017 | The p.D24G pathogenic mutation (also known as c.71A>G), located in coding exon 1 of the PTEN gene, results from an A to G substitution at nucleotide position 71. The aspartic acid at codon 24 is replaced by glycine, an amino acid with similar properties. This alteration has been reported in three individuals meeting relaxed International Cowden Consortium operational criteria for Cowden syndrome and was identified as a de novo mutation in an individual with a clinical diagnosis of Cowden syndrome in our internal cohort (Tan MH et al. Am. J. Hum. Genet. 2011 Jan; 88(1):42-56). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at